Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
How to ensure safety and quality in pharmaceutical facilities when using HPAPIs in drug development. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results